Get started
CEL-SCI CorporationCEL-SCI CorporationCEL-SCI Corporation

CEL-SCI Corporation

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsForecasts

Live chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪65.68 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−8.3350 EUR
Net income (FY)
‪−24.18 M‬ EUR
Revenue (FY)
0.00 EUR
Shares float
‪7.34 M‬
Beta (1Y)
1.77

About Cel-Sci Corporation


Sector
Health Technology
Industry
Biotechnology
CEO
Geert R. Kersten
Website
cel-sci.com
Headquarters
Vienna
Founded
1983
ISIN
US1508377066
CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Check out other big names from the same industry as A418TV.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of A418TV is 8.8500 EUR — it has decreased by −4.32% in the past 24 hours. Watch CEL-SCI Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LS exchange CEL-SCI Corporation stocks are traded under the ticker A418TV.
We've gathered analysts' opinions on CEL-SCI Corporation future price: according to them, A418TV price has a max estimate of 51.36 EUR and a min estimate of 51.36 EUR. Watch A418TV chart and read a more detailed CEL-SCI Corporation stock forecast: see what analysts think of CEL-SCI Corporation and suggest that you do with its stocks.
A418TV reached its all-time high on Oct 6, 2025 with the price of 9.2500 EUR, and its all-time low was 8.5000 EUR and was reached on Oct 3, 2025. View more price dynamics on A418TV chart.
See other stocks reaching their highest and lowest prices.
A418TV stock is 4.52% volatile and has beta coefficient of 1.77. Track CEL-SCI Corporation stock price on the chart and check out the list of the most volatile stocks — is CEL-SCI Corporation there?
Today CEL-SCI Corporation has the market capitalization of ‪65.68 M‬, it has increased by 3.28% over the last week.
Yes, you can track CEL-SCI Corporation financials in yearly and quarterly reports right on TradingView.
CEL-SCI Corporation is going to release the next earnings report on Dec 19, 2025. Keep track of upcoming events with our Earnings Calendar.
A418TV net income for the last quarter is ‪−4.81 M‬ EUR, while the quarter before that showed ‪−6.08 M‬ EUR of net income which accounts for 20.84% change. Track more CEL-SCI Corporation financial stats to get the full picture.
No, A418TV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, A418TV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CEL-SCI Corporation stock right from TradingView charts — choose your broker and connect to your account.